Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Expert Reviews in Molecular Medicine|May 19, 2004
Critical evaluation of p53 as a prognostic marker in ovarian cancerJacqueline Hall, Jim Paul, Robert Brown
Cancer Genomics & Proteomics|September 20, 2007
An exploration into study design for biomarker identification: issues and recommendationsJacqueline A Hall, Robert Brown, Jim Paul
Gynecologic Oncology|September 10, 2002
Does the interval from primary surgery to chemotherapy influence progression-free survival in ovarian cancer?Paul M Flynn, Jim Paul, Derek J Cruickshank, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 6, 2012
Survey on the management of early cervical cancer among members of the GCIGRhona Lindsay, Jim Paul, Nadeem Siddiqui, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2004
The acquisition of hMLH1 methylation in plasma DNA after chemotherapy predicts poor survival for ovarian cancer patientsGillian Gifford, Jim Paul, Paul A Vasey, et al.
The Lancet. Oncology|June 14, 2013
Depression and anxiety in long-term cancer survivors compared with spouses and healthy controls: a systematic review and meta-analysisAlex J Mitchell, David W Ferguson, John Gill, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 26, 2007
A randomised controlled trial of intervention site radiotherapy in malignant pleural mesotheliomaNoelle O'Rourke, Jose Curto Garcia, Jim Paul, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2007
Pharmacogenetic assessment of toxicity and outcome after platinum plus taxane chemotherapy in ovarian cancer: the Scottish Randomised Trial in Ovarian CancerSharon Marsh, Jim Paul, Cristi R King, et al.
Systematic Reviews|April 20, 2018
Protocol for a systematic review and thematic synthesis of patient experiences of central venous access devices in anti-cancer treatmentCaoimhe Ryan, Hannah Hesselgreaves, Olivia Wu, et al.
BMJ Open|October 21, 2015
Decision analytic cost-effectiveness model to compare prostate cryotherapy to androgen deprivation therapy for treatment of radiation recurrent prostate cancerKathleen A Boyd, Rob J Jones, Jim Paul, et al.
Pageof 3